Federated Hermes reports 8.51M shares (8.68%)

Federated Hermes, Inc. filed an amendment on Schedule 13G/A reporting beneficial ownership of 8,509,678 shares of common stock of aTYR PHARMA INC, equal to 8.68% of the class as shown on the cover pages dated 06/30/2026.

Rhea-AI Filing Summary

Federated Hermes, Inc. filed an amendment on Schedule 13G/A reporting beneficial ownership of 8,509,678 shares of common stock of aTYR PHARMA INC, equal to 8.68% of the class as shown on the cover pages dated 06/30/2026. The filing includes a Rule 13d-4 disclaimer that Federated Hermes, the Voting Shares Irrevocable Trust and related individuals expressly disclaim beneficial ownership of securities held by the managed funds.

Insights

Institutional Ownership Analyst

Large passive stake reported by Federated Hermes; ownership shown at 8.68%

The amendment lists 8,509,678 shares (8.68%) held or reported under Federated Hermes and affiliated reporting persons as of 06/30/2026. The filing follows Schedule 13G procedures and includes the specified Rule 13d-4 disclaimer about managed funds.

Cash-flow treatment and disposition plans are not stated; subsequent filings would show any trading. Regulatory classification and joint-filing exhibits are attached per the cover-page references.

Corporate Governance Counsel

Filing emphasizes legal attribution and joint-filing mechanics, not a claim of beneficial ownership

The disclosure includes identical voting and dispositive power entries for Federated Hermes and related trustees/individuals and an express disclaimer under Rule 13d-4. Exhibits cited include joint-filing and power-of-attorney documents.

These items document reporting structure; they do not state changes to voting arrangements or transfers. Timing references in signatures are 07/08/2026.

Key Figures

Filing type: Schedule 13G/A Shares reported: 8,509,678 shares Percent of class: 8.68% +3 more

6 metrics

Filing type Schedule 13G/A Amendment No. 11

Shares reported 8,509,678 shares reported beneficial ownership on cover pages

Percent of class 8.68% percent shown on cover pages

As-of date 06/30/2026 date shown on cover pages

CUSIP 002120202 aTYR PHARMA INC common stock

Signature dates 07/08/2026 executed signatures on amendment

Key Terms

Schedule 13G/A, Rule 13d-4 disclaimer, Dispositive power

3 terms

Schedule 13G/A regulatory

"Amendment No. 11) aTYR PHARMA INC COMMON STOCK"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Rule 13d-4 disclaimer regulatory

"expressly disclaim beneficial ownership of such securities"

Dispositive power financial

"Sole Dispositive Power 8,509,678.00"

Dispositive power is the authority to decide the final outcome of an asset, legal claim, contract, or corporate action — in effect the power to dispose of or resolve something. For investors it matters because whoever holds that authority can determine who gets paid, who controls an asset or vote, and how risks and returns are allocated; think of it like holding the key that lets you lock in the winner or loser in a deal.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does Federated Hermes report in aTYR (ATYR)?

Federated Hermes reports 8,509,678 shares, representing 8.68% of aTYR common stock as shown on the cover page dated 06/30/2026. The filing is an amended Schedule 13G/A reflecting that position.

Does the filing state Federated Hermes is the beneficial owner?

No. The filing contains a Rule 13d-4 disclaimer where Federated Hermes, the Voting Shares Irrevocable Trust, and named individuals expressly disclaim beneficial ownership of securities held by the managed funds.

Who else is named on the Schedule 13G/A for this position?

The filing names the Voting Shares Irrevocable Trust, Thomas R. Donahue, Ann C. Donahue, and J. Christopher Donahue with shared voting and dispositive power of 8,509,678 shares (8.68%).

What documents are attached to support the filing?

The filing references Exhibit 1 (Item 3 classification), Exhibit 2 (agreement for joint filing), and Exhibit 3 (power of attorney). Signature blocks show execution dates of 07/08/2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/08/2026 - 07:37 AM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 11)

aTYR PHARMA INC

(Name of Issuer)

COMMON STOCK

(Title of Class of Securities)

002120202

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 002120202

1

Names of Reporting Persons

Federated Hermes, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

PENNSYLVANIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 8,509,678.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 8,509,678.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

8,509,678.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.68 %

12

Type of Reporting Person (See Instructions)

HC

SCHEDULE 13G

CUSIP Number(s): 002120202

1

Names of Reporting Persons

Voting Shares Irrevocable Trust

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

PENNSYLVANIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 8,509,678.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 8,509,678.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

8,509,678.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.68 %

12

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person: In accordance with Rule 13d-4 under the Exchange Act, Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue declare that this report should not be construed as an admission that any of them is the beneficial owner of the securities held by any of the Managed Funds, and each of Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue expressly disclaim beneficial ownership of such securities.

SCHEDULE 13G

CUSIP Number(s): 002120202

1

Names of Reporting Persons

Thomas R. Donahue

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 8,509,678.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 8,509,678.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

8,509,678.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.68 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: In accordance with Rule 13d-4 under the Exchange Act, Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue declare that this report should not be construed as an admission that any of them is the beneficial owner of the securities held by any of the Managed Funds, and each of Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue expressly disclaim beneficial ownership of such securities.

SCHEDULE 13G

CUSIP Number(s): 002120202

1

Names of Reporting Persons

Ann C. Donahue

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 8,509,678.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 8,509,678.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

8,509,678.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.68 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: In accordance with Rule 13d-4 under the Exchange Act, Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue declare that this report should not be construed as an admission that any of them is the beneficial owner of the securities held by any of the Managed Funds, and each of Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue expressly disclaim beneficial ownership of such securities.

SCHEDULE 13G

CUSIP Number(s): 002120202

1

Names of Reporting Persons

J. Christopher Donahue

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 8,509,678.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 8,509,678.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

8,509,678.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.68 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: In accordance with Rule 13d-4 under the Exchange Act, Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue declare that this report should not be construed as an admission that any of them is the beneficial owner of the securities held by any of the Managed Funds, and each of Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue expressly disclaim beneficial ownership of such securities.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: aTYR PHARMA INC
(b)	Address of issuer's principal executive offices: 10240 Sorrento Valley Road, Suite 300, San Diego, CA 92121
Item 2.
(a)	Name of person filing: Federated Hermes, Inc.
(b)	Address or principal business office or, if none, residence: 1001 Liberty Avenue, Pittsburgh, PA 15222-3779
(c)	Citizenship: Pennsylvania
(d)	Title of class of securities: COMMON STOCK
(e)	CUSIP No.: 002120202
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: See response to Item 9 on each cover page.
(b)	Percent of class: See response to Item 11 on each cover page.
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: See response to Item 5 on each cover page.
	(ii) Shared power to vote or to direct the vote: See response to Item 6 on each cover page.
	(iii) Sole power to dispose or to direct the disposition of: See response to Item 7 on each cover page.
	(iv) Shared power to dispose or to direct the disposition of: See response to Item 8 on each cover page.
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. See Exhibit "1" Attached
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Federated Hermes, Inc.

Signature:	/s/J. Christopher Donahue
Name/Title:	J. Christopher Donahue, as President of Federated Hermes, Inc.
Date:	07/08/2026

Voting Shares Irrevocable Trust

Signature:	/s/Thomas R. Donahue
Name/Title:	Thomas R. Donahue, as Trustee of Voting Shares Irrevocable Trust
Date:	07/08/2026

Signature:	/s/Ann C. Donahue
Name/Title:	Ann C. Donahue, as Trustee of Voting Shares Irrevocable Trust
Date:	07/08/2026

Signature:	/s/J. Christopher Donahue
Name/Title:	J. Christopher Donahue, as Trustee of Voting Shares Irrevocable Trust
Date:	07/08/2026

Thomas R. Donahue

Signature:	/s/Thomas R. Donahue
Name/Title:	Thomas R. Donahue
Date:	07/08/2026

Ann C. Donahue

Signature:	/s/Ann C. Donahue
Name/Title:	Ann C. Donahue
Date:	07/08/2026

J. Christopher Donahue

Signature:	/s/J. Christopher Donahue
Name/Title:	J. Christopher Donahue
Date:	07/08/2026

Comments accompanying signature: SEE EXHIBITS 2 AND 3 ATTACHED Exhibit Information EXHIBIT 1 ITEM 3 CLASSIFICATION OF REPORTING PERSONS EXHIBIT 2 AGREEMENT FOR JOINT FILING OF SCHEDULE 13G EXHIBIT 3 POWER OF ATTORNEY